Skip to main content
Premium Trial:

Request an Annual Quote

Zymark to Acquire Belgian Distributor to Fatten European Footprint

NEW YORK, Sept. 6 - Zymark is set to announce on Monday it has acquired Labotec, the Belgian company responsible for selling Zymark's technology in Belgium, the Netherlands, and Luxembourg.

 

Labotec will become a wholly owned subsidiary of Zymark and change its name to Zymark Benelux, according to Zymark, which said it made the move to "reinforce its commitment" to the European market. (The term Benelux is commonly used when referring to the region in northern Europe comprising Belgium, the Netherlands, and Luxembourg.)

 

Jef Leemans, Labotec's founder, will become the managing director and direct of European service and support in the new company, Zymark said. He will report to Jean-Louis Rufener, vice president of Zymark's international operations.

 

Leemans also will join the directors of Zymark's subsidiaries in the United Kingdom, France, Germany, Switzerland, and Japan--each country a Zymark market.

 

Labotec, based in Teralfene, distributes a wide array of products, including equipment for chemical engineering, environmental technology, medical and veterinary pathology, textiles and clothing, pharmaceuticals, mining, according to the company's web site.

 

It was not immediately clear what the fate of these distribution channels will be once acquired by Zymark. Similarly, it was not clear what will happen to Labotec's existing employees.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.